Skip to main content
Pharmsville Co., Ltd. logo

Pharmsville Co., Ltd. — Investor Relations & Filings

Ticker · 318010 ISIN · KR7318010006 KO Manufacturing
Filings indexed 129 across all filing types
Latest filing 2022-03-17 Audit Report / Informat…
Country KR South Korea
Listing KO 318010

About Pharmsville Co., Ltd.

http://pharmsville.net/

Pharmsville Co., Ltd. is a bio-healthcare company that develops, produces, and sells health functional foods and natural supplements. Founded in 2000, the company focuses on extending human healthspan through the research and development of novel ingredients, with a specialization in microbiome-based probiotics. Its product portfolio is marketed to both domestic and international consumers under brands such as 'Appletree Dr.'. The company supports its innovation through dedicated research facilities, including the Pharmsville Bio Lab, aiming to create health products that are as natural as possible for the human body.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filing from the Korean regulatory system (KIND/KRX). It provides the auditor's opinion (적정/Unqualified), financial highlights (assets, liabilities, equity, profit/loss), and confirmation of the audit process. While it contains financial data, it is specifically a regulatory disclosure of the audit results rather than the full 10-K annual report itself. In the context of the provided categories, this fits best as an Audit Report/Information (AR) filing. FY 2021
2022-03-17 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Pharmsville. It contains the meeting agenda, details on voting, and financial statements (balance sheet, income statement, etc.) provided as reference materials for shareholders to review before the meeting. This type of document is a standard Proxy Solicitation & Information Statement (PSI) used to inform shareholders of upcoming votes and provide necessary background information.
2022-03-10 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company 'Farmsville'. It outlines the date, location, agenda items (financial statement approval, dividend declaration, and election of directors/auditors), and provides biographical details for the nominees. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2022-02-11 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement regarding a 'Cash/In-kind Dividend Decision' (현금ㆍ현물배당 결정) by the company Farmsville. It specifies the dividend amount per share, the dividend total, the record date, and the expected date of the general meeting for approval. This falls directly under the definition of a dividend announcement.
2022-02-11 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal notification filed by the company (Farmsville) regarding the scheduling of its Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the rationale for choosing this date and acknowledges the company's intent to comply with future dispersion guidelines. Since this is a regulatory notification regarding the meeting logistics rather than the meeting materials themselves or the voting results, it falls under the general regulatory filing category.
2022-02-11 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Farmsville) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report preliminary financial results before the final audit is completed. Since it provides key financial highlights (revenue, operating profit, net income) and explains the reasons for the change, it fits the definition of an Earnings Release (ER). FY 2021
2022-02-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.